The market presents significant opportunities driven by high demand for biologics and protein therapeutics, as well as ...

IBP-9414 will be the first live biotherapeutic product globally, according to officials at Infant Bacterial Therapeutics in Stockholm.

The global biopharmaceutical market is driven by the rising prevalence of chronic diseases and biotechnology advancements, ...

Solid Biosciences has secured US FDA rare paediatric disease designation for SGT-212, its investigational gene therapy targeting FA.

The colorectal cancer market is growing due to rising incidence driven by aging populations and lifestyle risk ...

The Global Plantibodies Market offers opportunities in cost-effective and scalable production with reduced pathogen risks. Leveraging plant-based systems, accelerated timelines, and AI-enhanced ...

Biologics Fill Finish Services Trends And Forecasts Report 2025: An $11.6 Billion Market By 2035, Driven By Oncology, Vials As Primary Packaging, And Rapid Expansion In Asia-Pacific. The biologics ...

The vaccine developers market shows significant opportunities through increased demand, collaborative partnerships, and ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...

SGT-212 has been granted FDA Rare Pediatric Disease and Fast Track designations –– SGT-212 is the only dual route gene therapy in development ...

Mycosis fungoides, the most prevalent CTCL subtype, accounts for the majority of cases. Although early-stage disease has a five-year survival rate of roughly 88%, it is a chronic cancer with ...

Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis" report has been added to ResearchAndMarkets.com's offering. The ...